Kenji Kawakami Selected Research

23-valent pneumococcal capsular polysaccharide vaccine

1/2020	A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) revaccination coverage rate among elderly adults aged 65 and older and physician's attitude.
1/2020	A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) coverage among patients with chronic medical condition aged 50 and older.
1/2018	Time interval of revaccination with 23-valent pneumococcal polysaccharide vaccine more than 5 years does not affect the immunogenicity and safety in the Japanese elderly.
1/2017	The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial.
1/2016	Revaccination with 23-valent pneumococcal polysaccharide vaccine in the Japanese elderly is well tolerated and elicits immune responses.
6/2015	Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenji Kawakami Research Topics

Disease

4	Infections 01/2017 - 01/2009
4	Pneumonia (Pneumonitis) 01/2017 - 07/2006
3	Lung Diseases (Lung Disease) 01/2020 - 02/2007
3	Tuberculosis (Tuberculoses) 01/2019 - 08/2002
3	Rheumatoid Arthritis 01/2017 - 06/2015
3	Pulmonary Tuberculosis 09/2007 - 08/2002
2	Pneumococcal Infections 01/2018 - 01/2016
2	Pneumococcal Pneumonia 01/2017 - 07/2006
2	Stroke (Strokes) 01/2016 - 09/2015
2	Paralysis (Palsy) 01/2016 - 09/2015
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 08/2011 - 07/2007
1	Liver Diseases (Liver Disease) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Neoplasms (Cancer) 11/2015
1	Hemiplegia (Spastic Hemiplegia) 09/2015
1	Rheumatic Diseases (Rheumatism) 06/2015
1	Autoimmune Diseases (Autoimmune Disease) 01/2013
1	Bacteremia 01/2009
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2008
1	Liver Failure 09/2007
1	Anisakiasis 03/2005

Drug/Important Bio-Agent (IBA)

6	23-valent pneumococcal capsular polysaccharide vaccineIBA 01/2020 - 06/2015
4	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2017 - 02/2007
3	Pharmaceutical PreparationsIBA 07/2007 - 08/2002
2	Polysaccharides (Glycans)IBA 12/2015 - 06/2015
2	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2010 - 08/2008
2	SteroidsIBA 01/2008 - 09/2007
2	ImmunosorbentsIBA 02/2007 - 03/2005
2	EnzymesIBA 02/2007 - 03/2005
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	heparin-binding hemagglutininIBA 01/2019
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2019
1	Crystallins (Crystallin)IBA 01/2019
1	AntigensIBA 01/2019
1	VaccinesIBA 01/2017
1	golimumab FDA Link 12/2015
1	Methotrexate (Mexate)FDA LinkGeneric 12/2015
1	VimentinIBA 11/2015
1	Keratins (Keratin)IBA 11/2015
1	Calbindin 2IBA 11/2015
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2013
1	GlucocorticoidsIBA 01/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2013
1	Kanamycin FDA Link 08/2011
1	Levofloxacin (Levaquin)FDA Link 08/2011
1	MacrolidesIBA 07/2006
1	Rifampin (Rifampicin)FDA LinkGeneric 08/2002
1	Isoniazid (Ftivazide)FDA LinkGeneric 08/2002
1	Pyrazinamide FDA LinkGeneric 08/2002

Therapy/Procedure

2	Therapeutics 01/2013 - 09/2007
2	Drug Therapy (Chemotherapy) 08/2011 - 08/2002
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2016
1	Electric Stimulation Therapy (Electrotherapy) 09/2015
1	Mirror Movement Therapy 09/2015
1	Catheters 01/2009
1	Pneumonectomy (Lung Volume Reduction) 07/2007